Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Cancers|September 9, 2023
Pre-Clinical Models to Study Human Prostate CancerMartin K Thomsen, Morten BuskSeminars in Nuclear Medicine|October 16, 2020
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future DirectionsMorten Busk, Jens Overgaard, Michael R HorsmanActa Oncologica (Stockholm, Sweden)|July 29, 2008
Resolution in PET hypoxia imaging: voxel size mattersMorten Busk, Michael R Horsman, Jens OvergaardActa Oncologica (Stockholm, Sweden)|August 31, 2013
Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapyAne B Iversen, Morten Busk, Michael R HorsmanActa Oncologica (Stockholm, Sweden)|August 22, 2019
Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumesMorten Busk, Michael R Horsman, Jens Overgaard, et al.EJNMMI Radiopharmacy and Chemistry|June 17, 2020
In vitro hypoxia responsiveness of [<sup>18</sup>F] FDG and [<sup>18</sup>F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scalingMorten Busk, Michael R Horsman, Jens Overgaard, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 15, 2010
Imaging tumour physiology and vasculature to predict and assess response to heatSteffen L Hokland, Thomas Nielsen, Morten Busk, et al.Acta Oncologica (Stockholm, Sweden)|August 26, 2017
Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificityMorten Busk, Ole L Munk, Steen S Jakobsen, et al.Plos One|August 15, 2015
Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In VitroBrita Singers Sørensen, Morten Busk, Jens Overgaard, et al.Vascular Pharmacology|November 3, 2010
Combretastatin-induced hypertension and the consequences for its combination with other therapiesMorten Busk, Anja Bille Bohn, Marianne Skals, et al.Pageof 6